David Soergel sold $517K of Madrigal Pharmaceuticals, Inc. (MDGL) stock

David Soergel, Chief Medical Officer of Madrigal Pharmaceuticals, Inc. (MDGL), sold 1,042 shares of MDGL stock worth $517K, per an SEC Form 4 filed Jun 1, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade was reported on Jun 1, 2026.

MDGL has moved +8.5% since the trade date, from $481.23 to $521.96 (Sep 21, 2026 close).